The Phoenix of Process Innovation
Out of the ashes of the UK’s former largest chemical manufacturer, a not-for-profit company dedicated to de-risking innovation has risen. This is the story behind CPI.
James Strachan, Stephanie Sutton | | Longer Read
Imperial Chemical Industries (ICI) once employed as many as 30,000 people in Teesside in the North East of England. The company’s history dated back to the 1920s and the demolition of its three 100 m cooling towers in 2012 signaled the end of an era for a region – and a community – defined by their industrial heritage.
Similar stories can be seen the world over. From the US “Rust Belt” to the industrial heartlands of Southern Ontario, Canada, to Bergslagen, Sweden, globalization has led to industrial decline, which can, in turn, influence social and economic issues.
Globalization is arguably one of the defining political issues of our time, with governments across the developed world thinking about how to reduce geographic inequality and create stable jobs in former industrial regions. One big hope for advanced economies is creating jobs in high value, high productivity industries, such as pharmaceutical manufacturing. The big stumbling block? The inherent risk of innovation.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.